请输入您要查询的百科知识:

 

词条 Insulin detemir
释义

  1. Medical use

  2. Side effects

  3. Chemistry

  4. Society and culture

  5. References

  6. External links

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464363066
| IUPAC_name =
| drug_name =
| tradename = Levemir
| Drugs.com = {{drugs.com|monograph|insulin_detemir}}
| MedlinePlus = a606012
| pregnancy_AU =
| pregnancy_US = B
| pregnancy_category =
| licence_EU = yes
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US = Rx-only
| legal_status =
| routes_of_administration = Subcutaneous
| bioavailability = 60% (when administered s.c.)
| protein_bound =
| metabolism =
| elimination_half-life = 5–7 hours
| excretion =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 169148-63-4
| ATC_prefix = A10
| ATC_suffix = AE05
| PubChem =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01307
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 4FT78T86XV
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04539
| C=267 | H=402 | N=64 | O=76 | S=6
| molecular_weight = 5913 g/mol
}}Insulin detemir, sold under the brand name Levemir among others, is a long-acting insulin used to treat diabetes mellitus type 1 and type 2.[1] It is used by injection under the skin.[1] It is effective for up to 24 hours.[1]

Common side effects include low blood sugar, allergic reactions, pain at the site of injection, and weight gain.[1] Use in pregnancy and breastfeeding appears safe.[1] It works by increasing the amount of glucose that tissues take in and decreasing the amount of glucose made by the liver.[2]

Insulin detemir was approved for medical use in the United States in 2005.[2] In the United Kingdom it costs the NHS about 2.80 £ per 100 units as of 2019.[3] In the United States the wholesale cost of this amount is about 29.50 USD.[4] In 2016 it was the 121st most prescribed medication in the United States with more than 6 million prescriptions.[5]

Medical use

It is used to treat diabetes mellitus type 1 and type 2.[2] With respect to blood sugar management, it appears to work at least as well as NPH insulin and insulin glargine.[2]

Side effects

Common side effects include low blood sugar, allergic reactions, pain at the site of injection, and weight gain.[2] Use in pregnancy and breastfeeding appears safe.[1]

Chemistry

It is an insulin analogue in which a fatty acid (myristic acid) is bound to the lysine amino acid at position B29. It is quickly absorbed after which it binds to albumin in the blood through its fatty acid at position B29. It then slowly dissociates from this complex.

Society and culture

On June 13, 2009, the U.S. Food and Drug Administration (FDA) issued a public health advisory for insulin determir after learning that 129,000 stolen vials reappeared and were being sold in the U.S. market. The FDA warned that the stolen vials "may not have been stored and handled properly and may be dangerous for patients to use." The stolen vials were identified as lots XZF0036, XZF0037, and XZF0038.[6]

References

1. ^{{cite web |title=Insulin detemir Pregnancy and Breastfeeding Warnings |url=https://www.drugs.com/pregnancy/insulin-detemir.html |website=Drugs.com |accessdate=3 March 2019 |language=en}}
2. ^{{cite web |title=Insulin Detemir Monograph for Professionals |url=https://www.drugs.com/monograph/insulin-detemir.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=3 March 2019 |language=en}}
3. ^{{cite book|title=British national formulary : BNF 76|date=2018|publisher=Pharmaceutical Press|isbn=9780857113382|pages=701|edition=76}}
4. ^{{cite web |title=NADAC as of 2019-02-27 |url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6 |website=Centers for Medicare and Medicaid Services |accessdate=3 March 2019 |language=en}}
5. ^{{cite web |title=The Top 300 of 2019 |url=https://clincalc.com/DrugStats/Top300Drugs.aspx |website=clincalc.com |accessdate=22 December 2018}}
6. ^{{cite web |url=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm166358.htm |accessdate=9 March 2019}}

External links

  • [https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d38d65c1-25bf-401d-9c7e-a2c3222da8af Insulin detemir DailyMed]
{{Oral hypoglycemics and insulin analogs}}{{Signaling peptide/protein receptor modulators}}{{DEFAULTSORT:Insulin Detemir}}

3 : RTT|Insulin receptor agonists|Insulin therapies

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/12 9:27:06